1 | 7529333 | Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. | J Virol | 1995 Feb |
2 |
2 | 7742549 | Overexpression of cyclin D2 in chronic B-cell malignancies. | Blood | 1995 May 15 |
2 |
3 | 7806527 | Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. | J Biol Chem | 1994 Dec 30 |
2 |
4 | 8033212 | Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. | Cell | 1994 Jul 15 |
1 |
5 | 8242751 | The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. | Cell | 1993 Nov 19 |
1 |
6 | 8268127 | IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A. | Int Immunol | 1993 Oct |
2 |
7 | 8382693 | Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. | J Biol Chem | 1993 Feb 25 |
2 |
8 | 8710379 | Tyrosine kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells. | Oncogene | 1996 Jul 18 |
1 |
9 | 8945475 | Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. | Nature | 1996 Dec 5 |
1 |
10 | 9655257 | Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. | Mol Carcinog | 1998 Jun |
1 |
11 | 10359571 | Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. | J Exp Med | 1999 Jun 7 |
10 |
12 | 10378783 | Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines. | Cancer Lett | 1999 Apr 26 |
1 |
13 | 10930570 | The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells. | FEBS Lett | 2000 Aug 4 |
4 |
14 | 11236942 | The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. | Leukemia | 2001 Feb |
1 |
15 | 11350919 | Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. | Clin Cancer Res | 2001 May |
1 |
16 | 11823472 | Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. | J Biol Chem | 2002 Apr 5 |
1 |
17 | 12375011 | Cyclin D2 expression in familial and sporadic breast cancer. | Oncol Rep | 2002 Nov-Dec |
1 |
18 | 12483537 | Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. | Oncogene | 2002 Dec 12 |
1 |
19 | 12517729 | Differential modulation of interleukin-2-and interleukin-4-mediated early activation of normal human B lymphocytes by the caspase inhibitor zVAD-fmk. | Eur Cytokine Netw | 2002 Oct-Dec |
1 |
20 | 12649303 | Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. | J Pharmacol Exp Ther | 2003 Jun |
4 |
21 | 12663518 | Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. | Carcinogenesis | 2003 Mar |
1 |
22 | 12684418 | Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. | Clin Cancer Res | 2003 Apr |
1 |
23 | 12771922 | Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. | Br J Cancer | 2003 May 19 |
3 |
24 | 12878861 | Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells. | Cancer Biol Ther | 2003 May-Jun |
2 |
25 | 12884287 | 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1. | Eur J Immunol | 2003 Aug |
1 |
26 | 12921950 | Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. | Leuk Res | 2003 Dec |
1 |
27 | 14612939 | Promoter methylation of cyclin D2 gene in gastric carcinoma. | Int J Oncol | 2003 Dec |
2 |
28 | 14660677 | A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. | J Biol Chem | 2004 Feb 13 |
1 |
29 | 14975735 | Heme controls the expression of cell cycle regulators and cell growth in HeLa cells. | Biochem Biophys Res Commun | 2004 Mar 12 |
1 |
30 | 14980522 | Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. | Exp Cell Res | 2004 Mar 10 |
1 |
31 | 15070696 | Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. | Blood | 2004 Apr 15 |
1 |
32 | 15103748 | Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins. | Croat Med J | 2004 Apr |
1 |
33 | 15116089 | Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. | Oncogene | 2004 Apr 29 |
1 |
34 | 15169570 | The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. | Retrovirology | 2004 Apr 13 |
1 |
35 | 15245432 | 17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. | J Invest Dermatol | 2004 Aug |
9 |
36 | 15328171 | Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. | Clin Cancer Res | 2004 Aug 15 |
1 |
37 | 15509806 | FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. | Mol Cell Biol | 2004 Nov |
2 |
38 | 15587392 | The effect of sodium butyrate in combination with ATRA on the proliferation/differentiation of SKM-1. | J Huazhong Univ Sci Technolog Med Sci | 2004 |
3 |
39 | 15870436 | Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. | J Natl Cancer Inst | 2005 May 4 |
1 |
40 | 16024653 | Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. | Cancer Res | 2005 Jul 15 |
1 |
41 | 16174765 | Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. | Blood | 2006 Jan 15 |
1 |
42 | 16182291 | The polycomb group gene product Mel-18 interacts with cyclin D2 and modulates its activity. | FEBS Lett | 2005 Oct 10 |
1 |
43 | 16632470 | Activated Jak2 with the V617F point mutation promotes G1/S phase transition. | J Biol Chem | 2006 Jun 30 |
1 |
44 | 16858664 | Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21. | Planta Med | 2006 Aug |
1 |
45 | 17343197 | [The effect of cyclin D2 shRNA on the proliferation and apoptosis of LP-1 cell]. | Zhonghua Xue Ye Xue Za Zhi | 2006 Oct |
1 |
46 | 17510244 | Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. | Endocrinology | 2007 Aug |
1 |
47 | 17634406 | Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. | Carcinogenesis | 2007 Sep |
1 |
48 | 18097580 | Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. | Oncol Rep | 2008 Jan |
1 |
49 | 18431519 | Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. | J Clin Invest | 2008 May |
4 |
50 | 18474441 | Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. | Cell Biol Int | 2008 Aug |
1 |